Immunological erythroblastopenia induced by HCO-60 as a solvent of enocitabine (BH-AC).

Ninomiya, H; Hanada, T; Nakazawa, M; Aoki, Y; Shibuya, A; Nagasawa, T; Abe, T

Ninomiya, H; Hanada, T; Nakazawa, M; Aoki, Y; Shibuya, A; Nagasawa, T; Abe, T.

Nihon Ketsueki Gakkai Zasshi ; 50(4): 777-83, 1987 Jul.

Article in En | MEDLINE | ID: mdl-3120451

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Castor Oil/analogs & derivatives; Cytarabine/analogs & derivatives; Erythroblasts/drug effects; Leukemia, Myeloid, Acute/drug therapy; Red-Cell Aplasia, Pure/chemically induced; Solvents/adverse effects; Adult; Castor Oil/adverse effects; Cytarabine/therapeutic use; Erythroblasts/immunology; Hematopoietic Stem Cells/drug effects; Hematopoietic Stem Cells/immunology; Humans; Leukemia, Myeloid, Acute/blood; Male; Red-Cell Aplasia, Pure/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas Main subject: Solvents / Castor Oil / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Erythroblasts / Red-Cell Aplasia, Pure / Cytarabine Language: En Journal: Nihon Ketsueki Gakkai Zasshi Year: 1987 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links